Analysis

A severe downgrade from Citigroup has triggered a significant sell-off in Gemini Space Station stock, compounding the challenges the company...

Biopharmaceutical firm CytomX Therapeutics has positioned itself for a significant clinical push following a substantial equity raise. The company confirmed...

For shareholders of Gene Biotherapeutics, the wait for substantive news continues. The company, formerly known as Taxus Cardium Pharmaceuticals Group,...

The small-cap technology sector is currently experiencing significant dynamism, driven by trends in AI infrastructure and high-performance computing. Within this...

The optical networking specialist Lumentum has laid out a bold financial roadmap, aiming to dramatically accelerate its business growth. The...

The biopharmaceutical giant AbbVie finds itself navigating a complex landscape where promising research initiatives are counterbalanced by resurgent legal challenges....

In a decisive move to secure its financial future, New Fortress Energy has announced a sweeping restructuring agreement with its...

The US food distribution giant Sysco finds itself navigating a period of transition within its financial leadership. As Brandon Sewell...

Precision Biosciences is solidifying its clinical development strategy, with a pivotal trial for a Duchenne muscular dystrophy (DMD) treatment taking...

The initial euphoria surrounding artificial intelligence is giving way to a more sober assessment for software providers like Figma. Investors...